Aspirin found to greatly decrease covid hospitalizations
(Natural News) New research out of George Washington University (GWU) has found that over-the-counter aspirin could help to protect the lungs of patients who test “positive” for the Wuhan coronavirus (Covid-19). An investigative team looked at more than 400 Chinese Virus patients from hospitals across the United States who take aspirin for some other unrelated... (Source: NaturalNews.com)
Source: NaturalNews.com - October 25, 2021 Category: Consumer Health News Source Type: news

Oct 22 2021 This Week in Cardiology Oct 22 2021 This Week in Cardiology
Aspirin for primary prevention, induced hypothermia, half-dose DOAC, and social media, are the topics John Mandrola, MD, discusses in this week ’s podcast.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - October 22, 2021 Category: Cardiology Tags: Cardiology Commentary Source Type: news

Antithrombotic Therapy Not Warranted in COVID-19 Outpatients Antithrombotic Therapy Not Warranted in COVID-19 Outpatients
In stable patients with COVID-19, use of aspirin or apixaban did not reduce the rate of the composite of all-cause mortality, thromboembolism, MI, stroke, or hospitalization in the ACTIV-4B trial.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - October 20, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

Low-dose aspirin has limited benefits in adults without heart disease
Yale School of Medicine experts discuss emerging guidance on the overall benefit of aspirin therapy in older adults, and why talking to a doctor can help. (Source: Yale Science and Health News)
Source: Yale Science and Health News - October 20, 2021 Category: Universities & Medical Training Source Type: news

Heart attack: Over 60s warned not to take common painkiller - 'potentially serious' risk
ASPIRIN can help to prevent heart attacks and strokes in people at high risk, according to the NHS. However, new advice from US researchers shows that over 60s shouldn't take this medication as there is another risk that cancels out the benefits. (Source: Daily Express - Health)
Source: Daily Express - Health - October 20, 2021 Category: Consumer Health News Source Type: news

Aspirin Lowered Preeclampsia Risk in Real-World Lupus Study Aspirin Lowered Preeclampsia Risk in Real-World Lupus Study
A prospective, single-center study of pregnancies during 1995 –2020 showed a reduced risk for preeclampsia among high-risk women with systemic lupus erythematous who received low-dose aspirin.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 19, 2021 Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news

Full Suite of Innovations from Carestream Dental Opens New Treatment Options for GPs, Takes Teams from Case Start to Finish Faster
 Full Suite of Innovations from Carestream Dental Opens New Treatment Options for GPs, Takes Teams from Case Start to Finish Faster LAS VEGAS —After a long stretch without trade shows, doctors and team members are excited to explore all the latest technology at ADA SmileCon 2021. In Carestream Dental ’s booth, C1201, they’ll find the integrated solutions that will help them offer new treatment options; open new lines of revenue and engage with their patients better. The highly anticipated CS 3800 wireless intraoral scanner will be available for dental teams to experience. When microns matte...
Source: Dental Technology Blog - October 19, 2021 Category: Dentistry Source Type: news

USPSTF Statement on Aspirin: Poor Messaging at Best USPSTF Statement on Aspirin: Poor Messaging at Best
Could the messaging around the U.S. Preventive Services Task Force's draft aspirin recommendations put some patients who likely benefit at risk?theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - October 19, 2021 Category: Cardiology Tags: Cardiology Expert Column Source Type: news

Johnson & Johnson Reports Q3 2021 Results
New Brunswick, N.J. (October 19, 2021) – Johnson & Johnson (NYSE: JNJ) today announced results for third-quarter 2021. “Our third-quarter results demonstrate solid performance across Johnson & Johnson, driven by robust above-market results in Pharmaceuticals, ongoing recovery in Medical Devices, and strong growth in Consumer Health,” said Alex Gorsky, Chairman and Chief Executive Officer. “In the face of evolving marketplace dynamics resulting from the effects of COVID-19 and other global trends, we have continued to demonstrate the responsiveness and agility required to meet the needs of ou...
Source: Johnson and Johnson - October 19, 2021 Category: Pharmaceuticals Tags: Financial Source Type: news

Antithrombotic Therapy Not Helpful for COVID - 19 Outpatients
Major adverse cardiopulmonary outcomes not reduced with aspirin, apixaban versus placebo for clinically stable COVID - 19 outpatients (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - October 18, 2021 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Infections, Internal Medicine, Pharmacy, Pulmonology, Journal, Source Type: news

Aspirin side effects: The signs warning you may be at 'risk of disability and death'
ASPIRIN is currently the first resort for a host of ailments, but recommendations are now changing in light of mounting evidence indicating the benefits of the drug may not outweigh the risks. Some signs that the drug is doing considerable harm to your body may reflect in your stool. (Source: Daily Express - Health)
Source: Daily Express - Health - October 13, 2021 Category: Consumer Health News Source Type: news

Advice Shifts on Daily Aspirin for Heart Attack Prevention
Title: Advice Shifts on Daily Aspirin for Heart Attack PreventionCategory: Health NewsCreated: 10/12/2021 12:00:00 AMLast Editorial Review: 10/13/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - October 13, 2021 Category: Cardiology Source Type: news

Advice shifting on aspirin use for preventing heart attacks
Older adults without heart disease shouldn't take daily aspirin to prevent a first heart attack or stroke (Source: ABC News: Health)
Source: ABC News: Health - October 13, 2021 Category: Consumer Health News Tags: Health Source Type: news

Aspirin Use to Prevent 1st Heart Attack or Stroke Should Be Curtailed, U.S. Panel Says
Adults at high risk for cardiovascular disease may face serious side effects if they start a daily regimen of low-dose aspirin. (Source: NYT Health)
Source: NYT Health - October 12, 2021 Category: Consumer Health News Authors: Roni Caryn Rabin Tags: Aspirin Preventive Medicine Heart Colon and Colorectal Cancer Stroke Doctors Agency for Healthcare Research and Quality United States Preventive Services Task Force American College of Cardiology American Heart Assn your-feed-healthcar Source Type: news

USPSTF Rules Out Aspirin for Over 60s in Primary CVD Prevention USPSTF Rules Out Aspirin for Over 60s in Primary CVD Prevention
Draft recommendations suggest those aged 40-59 at low bleeding but high CVD risk may consider aspirin for prevention, but advise against it in those 60 and older, or for colorectal cancer prevention.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - October 12, 2021 Category: Cardiology Tags: Cardiology News Alert Source Type: news

If You Take Aspirin Every Day For Your Heart, Read This
The U.S. Preventive Services Task Force is considering updating its guidance on taking a daily aspirin. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - October 12, 2021 Category: Consumer Health News Source Type: news

New Guidelines Could Shift How People Prevent Heart Disease And Stroke
The U.S. Preventive Services Task Force is considering updating its guidance on taking a daily aspirin to prevent cardiovascular issues. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - October 12, 2021 Category: Consumer Health News Source Type: news

U.S. Task Force Reconsiders Daily Low-Dose Aspirin Use for Preventing Heart Attacks in Adults Over 60
Older adults without heart disease shouldn’t take daily low-dose aspirin to prevent a first heart attack or stroke, an influential health guidelines group said in preliminary updated advice released Tuesday. Bleeding risks for adults in their 60s and up who haven’t had a heart attack or stroke outweigh any potential benefits from aspirin, the U.S. Preventive Services Task Force said in its draft guidance. For the first time, the panel said there may be a small benefit for adults in their 40s who have no bleeding risks. For those in their 50s, the panel softened advice and said evidence of benefit is less clear....
Source: TIME: Health - October 12, 2021 Category: Consumer Health News Authors: Lindsey Taylor/AP Tags: Uncategorized healthscienceclimate Research wire Source Type: news

Older adults shouldn't start daily aspirin to prevent heart attacks, experts say
People age 60 and older should not start taking aspirin daily to prevent heart attacks and strokes because of the increased risk for internal bleeding, according to new draft recommendations. (Source: Health News - UPI.com)
Source: Health News - UPI.com - October 12, 2021 Category: Consumer Health News Source Type: news

Aspirin use to prevent 1st heart attack or stroke should be curtailed, US panel says
The U.S. panel also plans to retreat from its 2016 recommendation to take baby aspirin for the prevention of colorectal cancer, guidance that was groundbreaking at the time. The panel said that more recent data had raised questions about the putative benefits for cancer, and that more research was needed. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - October 12, 2021 Category: Pharmaceuticals Source Type: news

Mothers at risk of suffering pre-eclampsia should be given aspirin to stop condition, US medics
The US Preventive Services Task Force's, an independent advisory panel of doctors, claim it cuts the risk of expectant mothers being struck down with the common complication. (Source: the Mail online | Health)
Source: the Mail online | Health - September 28, 2021 Category: Consumer Health News Source Type: news

Women With Type 2 Diabetes Get Fewer Cardioprotective Drugs Than Men Women With Type 2 Diabetes Get Fewer Cardioprotective Drugs Than Men
A post-hoc analysis of REWIND shows underuse of statins and aspirin in women with type 2 diabetes compared with men with the same disease.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - September 28, 2021 Category: Neurology Tags: Diabetes & Endocrinology News Source Type: news

New Phase 3 Data Suggest Positive Effect and Show Similar Safety with XARELTO ® (rivaroxaban) Compared to Aspirin in Pediatric Fontan Procedure Patients at Risk for Blood Clots and Blood Clot-Related Events
RARITAN, NJ, September 27, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new data from the Phase 3 UNIVERSE study showing treatment with XARELTO® (rivaroxaban) in an oral suspension formulation, compared to treatment with aspirin, was associated with numerically fewer blood clots and clinical events strongly associated with blood clots in pediatric patients (aged 2-8 years) who have undergone the Fontan procedure. [1] These findings, which were published this month in the Journal of the American Heart Association and included in a recent New Drug Application submitted to the...
Source: Johnson and Johnson - September 27, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Aspirin and Heparin Increase Bleeding Risk During EVT Aspirin and Heparin Increase Bleeding Risk During EVT
New data from MR CLEAN-MED show that aspirin and heparin, alone or in combination, double the risk for symptomatic intracranial hemorrhage when given during endovascular therapy (EVT) for ischemic stroke.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - September 15, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Aspirin Boosts Polypill Primary Prevention, Claims Meta-Analysis Aspirin Boosts Polypill Primary Prevention, Claims Meta-Analysis
Polypills or other fixed-dose CV drug combos -- with or without aspirin, but especially with -- substantially cut risk in a meta-analysis of primary-prevention trials with a controversial message.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 3, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

Effect of NSAIDs and APT on Incidence and Recurrence of HCC Effect of NSAIDs and APT on Incidence and Recurrence of HCC
This study investigated whether NSAIDs or aspirin might have an impact on hepatocellular carcinoma incidence or recurrence among high-risk persons with chronic liver disease.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 1, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

FDA Approves Expanded Peripheral Artery Disease (PAD) Indication for XARELTO ® (rivaroxaban) Plus Aspirin to Include Patients After Lower-Extremity Revascularization (LER) Due to Symptomatic PAD
RARITAN, N.J., August 24, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded peripheral artery disease (PAD) indication for the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) to include patients following recent lower-extremity revascularization (LER) due to symptomatic PAD. The approval is based on data from the Phase 3 VOYAGER PAD study. With this approval, XARELTO® is the first and only therapy indicated to help reduce the risks of major cardiovascular (CV) e...
Source: Johnson and Johnson - August 24, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Scientist says yet more uses of aspirin may emerge in time
Research suggesting its benefits range from staving off cancer to boosting the odds of pregnancy. Even perking up a man's love life may be within its powers. (Source: the Mail online | Health)
Source: the Mail online | Health - August 23, 2021 Category: Consumer Health News Source Type: news

Aspirin trialled as potential treatment for aggressive breast cancer
Hopes raised that drug could work well with immunotherapy for triple-negative breast cancer patientsAspirin is being trialled as part of a potential treatment for an aggressive form of breast cancer.Researchers hope the cheap and widely available drug could work well when combined with immunotherapy for patients with triple-negative breast cancer.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - August 18, 2021 Category: Science Authors: PA Media Tags: Breast cancer Aspirin Health Science Society Medical research UK news Source Type: news

Aspirin as VTE Prophylaxis in Total Joint Arthroplasty Aspirin as VTE Prophylaxis in Total Joint Arthroplasty
Is prophylactic aspirin safe and effective in preventing VTE after total hip and knee arthroplasty procedures?Current Orthopaedic Practice (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 18, 2021 Category: Consumer Health News Tags: Orthopaedics Journal Article Source Type: news

Researchers launch clinical trial to see if aspirin could treat aggressive breast cancer
Researchers hope the cheap and widely available drug could work well when combined with immunotherapy for patients with triple negative breast cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - August 18, 2021 Category: Consumer Health News Source Type: news

Aspirin may help treat aggressive breast cancer
Doctors hope it could boost the anti-cancer power of other drugs to fight hard-to-treat tumours. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - August 17, 2021 Category: Consumer Health News Source Type: news

Timing of Aspirin Use in Colorectal Cancer Chemoprevention Timing of Aspirin Use in Colorectal Cancer Chemoprevention
Aspirin use can help lower the risk of colorectal cancer, but what is the optimal timing for initiation?Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 12, 2021 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

I ’m Your Man review – Dan Stevens is the perfect date in android romance
Near-future tale of a woman who accepts a male ‘companion’ robot played by Stevens is laboriously told and not really funny enoughDirected by Maria Schrader, this was a crowd-pleasing favourite at the Berlin film festival earlier this year and its star, Maren Eggert, won the festival ’s new gender-neutral best leading performance prize. But I was disappointed with a film whose crises and dilemmas seem laborious and essentially predictable; it does not fully work as sci-fi or satire or comedy.We are in a world of the near-future (and the city of Berlin itself is certainly very plausible as its location). E...
Source: Guardian Unlimited Science - August 11, 2021 Category: Science Authors: Peter Bradshaw Tags: Film Comedy films Science fiction and fantasy films Dan Stevens Germany Artificial intelligence (AI) World news Technology Europe Culture Consciousness Computing Human biology Neuroscience Psychology Source Type: news

Low-Dose Aspirin Linked to Lower Dementia Risk
in Some Individuals (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - August 4, 2021 Category: General Medicine Source Type: news

Low-Dose Aspirin Linked to Lower Dementia Risk in Some Low-Dose Aspirin Linked to Lower Dementia Risk in Some
Two cohorts suggest long-term use of low-dose aspirin may be beneficial ― but primarily in those with cardiovascular risk.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - August 4, 2021 Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news

NSAIDs, Polygenic Risk Score and Colorectal Cancer Risk NSAIDs, Polygenic Risk Score and Colorectal Cancer Risk
This study adds to the evidence indicating that regular use of NSAIDs or aspirin is associated with lower colorectal cancer risk, irrespective of individual polygenic risk.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 2, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Prefer DOACs Over Aspirin After Ventricular Ablations: STROKE-VT Prefer DOACs Over Aspirin After Ventricular Ablations: STROKE-VT
Cerebrovascular protection was far better on DOACs after catheter ablation for VT or extrasystoles in the trial. There might be changes some operators can make to lower the risk even further.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 30, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

Associations of Aspirin and NSAIDs and CRC Mortality Associations of Aspirin and NSAIDs and CRC Mortality
What are the potential benefits and harms of aspirin and NSAID use on colorectal cancer mortality outcomes?Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 29, 2021 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Meet the Patients Who Helped Run a Big Aspirin Trial Meet the Patients Who Helped Run a Big Aspirin Trial
WebMD Health News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 23, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

P2Y12 Inhibitors+Aspirin vs. Aspirin Alone in Minor Stroke P2Y12 Inhibitors+Aspirin vs. Aspirin Alone in Minor Stroke
This review compared the effectiveness and safety of DAPT therapy with P2Y12 inhibitors and aspirin versus aspirin monotherapy in patients with mild ischemic stroke or high-risk TIA.Stroke (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - July 22, 2021 Category: Intensive Care Tags: Neurology & Neurosurgery Journal Article Source Type: news

Is Aspirin Overused in Older Patients With Diabetes? Is Aspirin Overused in Older Patients With Diabetes?
A study of trends in aspirin use in older US adults finds those with diabetes are twice as likely to use aspirin for primary prevention as those without diabetes; many patients might now need review.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 16, 2021 Category: Cardiology Tags: Diabetes & Endocrinology News Source Type: news

Ticagrelor Beneficial for Moderate Stroke: New THALES Analysis Ticagrelor Beneficial for Moderate Stroke: New THALES Analysis
For patients with a moderate-size stroke, the benefit from ticagrelor plus aspirin is the same as for patients with minor stroke, a new exploratory analysis of the THALES trial shows.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - July 16, 2021 Category: Emergency Medicine Tags: Neurology & Neurosurgery News Source Type: news

Low - Dose Aspirin Cuts Heart Risks in Patients Battling Pneumonia
(Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - July 8, 2021 Category: Respiratory Medicine Tags: Cardiology, Family Medicine, Neurology, Pulmonology, News, Source Type: news

Low-Dose Aspirin Cuts Heart Risks in Patients Battling Pneumonia
THURSDAY, July 8, 2021 -- Aspirin has long been taken by heart patients to reduce the risk of stroke and heart attack, but a new study suggests that it can also guard against cardiovascular trouble in pneumonia patients. Such complications are... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 8, 2021 Category: General Medicine Source Type: news

Low-Dose Aspirin Cuts Heart Risks in Patients Battling Pneumonia
Title: Low-Dose Aspirin Cuts Heart Risks in Patients Battling PneumoniaCategory: Health NewsCreated: 7/8/2021 12:00:00 AMLast Editorial Review: 7/8/2021 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - July 8, 2021 Category: Cardiology Source Type: news

Study shows aspirin can reduce the risk of heart attacks and strokes in patients with pneumonia
Aspirin can reduce the risk of serious cardiovascular events such as ischemic stroke and heart attack in patients with pneumonia, according to new research. (Source: University of Bristol news)
Source: University of Bristol news - July 7, 2021 Category: Universities & Medical Training Tags: Research; Faculty of Health Sciences, Faculty of Health Sciences, Bristol Medical School; Press Release Source Type: news

DAPT vs. Aspirin in Patients With Stroke or TIA DAPT vs. Aspirin in Patients With Stroke or TIA
This study found that compared with aspirin alone, DAPT given within 24 hours of high-risk TIA or mild to moderate stroke reduces the risk of recurrent stroke, but comes with higher risk of bleeding.Stroke (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 5, 2021 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

Taking aspirin can slash your chance of dying from cancer by a fifth
ASTONISHING research uncovered the potential life-saving capabilities of aspirin. Professor Peter Elwood and his team from Cardiff University found that the painkiller dramatically "cut the risk of death" in cancer patients. (Source: Daily Express - Health)
Source: Daily Express - Health - July 4, 2021 Category: Consumer Health News Source Type: news

FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes
[FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes (FDA Drug Safety Communication). Based on FDA ’s comprehensive review of new safety information, the agency is requiring updates to the drug labels of all prescription NSAIDs. Widely used to treat pain and fever from many different long- and short-term medical conditions such as arthritis, menstrual cramps, headaches, colds, and the flu, NSAI Ds are available by prescription and OTC. Examples of NSAIDs include ibuprofen, naproxen, diclofenac, and celecoxib. (Source: FDA Center for Drug Evaluation...
Source: FDA Center for Drug Evaluation and Research - What's New - June 29, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news